参考文献/References:
[1]刘健,闫秀娥,周丽雅,等.胃液固有荧光光谱在胃癌诊断中的应用进展.中国微创外科杂志,2018,18(1):64-67.
[2]Deng K,Lin S,Zhou L,et al.Three aromatic amino acids in gastric juice as potential biomarkers for gastric malignancies.Anal Chim Acta,2011,694(1-2):100-107.
[3]Deng K,Lin S,Zhou L,et al.High levels of aromatic amino acids in gastric juice during the early stages of gastric cancer progression.PLoS One,2012,7(11):e49434.
[4]Huang L,Xu A.Detection of digestive malignancies and post-gastrectomy complications via gastrointestinal fluid examination.Front Med,2017,11(1):20-31.
[5]Pinheiro Ddo R,Ferreira WA,Barros MB,et al.Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications.World J Gastroenterol,2014,20(33):11574-11585.
[6]Wu W,Chung MC.The gastric fluid proteome as a potential source of gastric cancer biomarkers.J Proteomics,2013,90:3-13.
[7]Wiggins T,Kumar S,Markar SR,et al.Tyrosine,phenylalanine,and tryptophan in gastroesophageal malignancy: a systematic review.Cancer Epidemiol Biomarkers Prev,2015,24(1):32-38.
[8]Li ZP,Li Y,Liu J,et al.Overexpression of cytoplasmic p62 protein is associated with poor prognosis in gastric adenocarcinoma.Int J Clin Exp Pathol,2016,9(8):8492-8498.
[9]Hwang TL,Lee LY,Wang CC,et al.Claudin-4 expression is associated with tumor invasion,MMP-2 and MMP-9 expression in gastric cancer.Exp Ther Med,2010,1(5):789-797.
[10]Ruan HL,Hong RT,Xie HJ,et al.Significance of elevated levels of collagen type Ⅳ and hyaluronic acid in gastric juice and serum in gastric cancer and precancerous lesion.Dig Dis Sci,2011,56(7):2001-2008.
[11]Wang HL,Zhou PY,Zhang Y,et al.Relationships between abnormal MMP2 expression and prognosis in gastric cancer:a meta-analysis of cohort studies.Cancer Biother Radiopharm,2014,29(4):166-172.
[12]Chen J,Chen LJ,Zhou HC,et al.Prognostic value of matrix metalloproteinase-9 in gastric cancer:a meta-analysis.Hepatogastroenterology,2014,61(130):518-524.
[13]Bornschein J,Seidel T,Langner C,et al.MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression.Diagn Pathol,2015,10:212.
[14]Gurgel DC,Valena-Junior JT,Dornelas CA,et al.Immunoexpression of metalloproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis.Pathol Oncol Res,2015,21(1):73-81.
[15]Bergin PJ,Anders E,Sicheng W,et al.Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis.Helicobacter,2004,9(3):201-210.
[16]Brown GT,Murray GI.Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis.J Pathol,2015,237(3):273-281.
[17]Peng CW,Liu XL,Liu X,et al.Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance.J Transl Med,2010,8:101.
[18]Mrena J,Wiksten JP,Nordling S,et al.MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.J Clin Pathol,2006,59(6):618-623.